In this study, Franchitto et al. [57] used lymphoblastoid cell lines obtained from 3 controls and 7 LS patients carrying mutations either in MLH1 (6 patients) or MSH2 (1 patient) at the heterozygous state. This evidence concerns the gene MSH2 and Leigh syndrome.